How much sample does it collect?

A controlled volume of approximately 40-50 microlitres, suitable for quantitative, low-abundance biomarker analysis.

Is ABEL suitable for proteomics and multi-omics?

Yes. The sample is compatible with most omics workflows, including proteomics, multi-omics and microbiome analysis.

Researchers, clinicians running studies, biobanks, and biotech and pharmaceutical teams who need consistent, omics-grade nasal samples.

Duplicate-Abel Microsampler

Q: What is ABEL's regulatory status?

ABEL is listed with the U.S. FDA and registered on the Australian ARTG as a Class I device for research applications. It is not a diagnostic or clinical tool, and FDA listing is not the same as FDA approval.

Q: How are samples stored and transported?

ABEL uses a self-contained cryovial cap. Storage and transport conditions are analyte-dependent, ranging from room temperature to -80C, with ambient shipping compatible for many analytes.

WHat it is

The device leading the future of nasal liquid biopsy

The ABEL Microsampler is a TGA and FDA-listed Class 1 device designed for nasal liquid biopsy.

Minimally invasive, its standout feature is an absorptive, expandable probe that collects site and volume specific samples, allowing for the collection of multi-omics-grade material from multi-centre and longitudinal biomarker studies.

The ABEL Microsampler is also the integral collection device behind the RhinoMAP platform.

Explore Full Technical Details

WHy abel

Built for sample quality you can trust

Omics quality sample

Collection of nasal epithelial lining fluid via the sampler yields high quality samples for omics analyses.

Controlled volume

Nasal liquid biopsy with one device collects consistent volumes, removing the unknown dilution factor that complicates lavage-based sampling.

High site-specificity

Reproducible collection from the anterior inferior turbinate means you sample the same location every time, which is essential for valid longitudinal comparison.

Minimally invasive

Low mucosal irritation captures inflammatory markers that reflect underlying disease rather than sampling trauma.

How Abel compares

Standardising what swabs and lavage leave to chance

Attribute	ABEL Microsampler®	Traditional nasal swab	Nasal lavage
Sample type	Mainly nasal mucosal-lining fluid	Nasal fluid, cells & debris	Diluted nasal fluid
Volume collected	Controlled	Highly variable	1–5 mL saline recovery
Biomarker yield	Suitable for low-abundance analytes	Inconsistent; possible blood contamination	Low analyte recovery
Ease of use	Intuitive, minimally operator-dependent	Highly operator-dependent	Highly operator-dependent
Site specificity	High (fixed geometry & depth)	Low	Low
Omics suitability	High	Variable	Lower

Proven in research

001

600+

used in respiratory clinical studies

002

7,000+

in active & pipeline studies

003

100K+

biomarker data points

004

2025

Good Design Award winner

How it works

Collect to analyse in four steps

Data · Storage/Transport conditions are analyte-dependent

1

Step 01

Collect

User-friendly nasal liquid biopsy, consistent and repeatable, no specialist required.

2

Step 02

Store

Self-contained cryovial cap; room temperature to −80°C (analyte-dependent).

3

Step 03

Transport

Ambient shipping compatible (analyte-dependent).

4

Step 04

Analyse

Compatible with proteomics, microbiome and broader omics workflows.

Applications

One device, many research frontiers

Respiratory & infectious disease

Multi-omics

Oncology

Neurology

Environmental & occupational exposure

Public health & Longevity

what the research says

Trusted from discovery to development

Data · Real testimonials — attribute by role + region

“

The ABEL Microsampler will be a game-changer for our research — it bridges critical gaps in sampling methodologies and helps us set a new standard for nasal fluid research.

A/Prof of Otolaryngology, Florida

“

A straightforward, efficient and effective method of nasal sample collection. It’s exciting what this product can offer to the future of respiratory medicine.

Clinical Research Nurse, Melbourne

“

Huge potential in clinical practice. A comfortable, reproducible nasal sampler could make regular monitoring part of routine care.

Otolaryngologist, Texas

“

Very straightforward to use. Easy and intuitive to handle. Would happily use again.

Clinical Research Nurse, Melbourne

Focus Conditions

Conditions studied with ABEL

Asthma

Chronic rhinosinusitis

COPD

Allergic rhinitis

Find Out More

Focus Conditions

FAQs

Common questions

What is the ABEL Microsampler?

ABEL is a minimally invasive nasal liquid biopsy device. It uses an absorptive, expandable probe to collect nasal mucosal-lining fluid for omics-grade research. This allows the device to provide a controlled, repeatable sample with minimal discomfort.

How is it different from a nasal swab or lavage?

ABEL wicking promoted consistent volume, high site-specificity, and a cleaner, lower-contamination sample better suited to downstream omics analysis.

Is ABEL suitable for proteomics / multi-omics?

Yes, ABEL is highly compatible with most omics workflows.

How are samples stored and transported?

Self-contained cryovial cap; room temperature to –80°C storage and ambient shipping. Storage and transport is analyte-dependent.

Is ABEL FDA approved?

It is FDA-listed and ARTG-registered as a Class I device for research applications. It is not a cleared diagnostic, and not approved in other jurisdictions.

What research areas is ABEL used in?

ABEL Microsamplers have broad research applications including respiratory, infectious disease, oncology, neurology, environmental/occupational health, and pharmaceutical trials.

Find Out More